Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata

Autores
Galera, Ivana Laura Delia; Páez, Paulina Laura; Paraje, María Gabriela
Año de publicación
2021
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient population. Among the NAC species, Candida glabrata is considered the second or third most frequent causative agent of superficial (oral, esophageal, urinary, and vaginal) or systemic infections, with a high mortality rate. These infections are difficult to treat for their innate resistance to many azole antifungals (ATF) therapy, especially fluconazole. Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents. Silver nanoparticles (AgNPs) are very interesting products currently provided by available nanotechnology to evaluate their antifungal activity. In the present study, the synergism of AgNPs in combination with amphotericin B (AmB) against C. glabrata was investigated. Biogenic AgNPs were synthesized by eco-friendly method, and the antifungal activity against C. glabrata ATCC 2001 was evaluated through determination of Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) according to protocol M27-A3 of Clinical and Laboratory Standards Institute (CLSI). The checkerboard microdilution method was used to study the synergistic combinations of AgNPs with AmB. The results were analyzed using the Fractionary Inhibitory Concentration (FIC) indices, a non-parametric model based on the Loewe additivity theory, and by CompuSyn software. CompuSyn is a computer program for quantitation of synergism and antagonism in drug combinations and the determination of IC50 (drug concentration causing 50% growth inhibition) and ED50 (dose causing 50% of maximum effect) values. Furthermore, we investigated the effects of the resazurin reduction (alamarBlue) assay, which measured metabolically active cells. The same MIC and MFC values were found for AgNP 0.13 pM and for AmB 2.7x105 pM. The FIC index was 0.37 (a FIC index of < 0.5 indicates synergism). This value corresponded to 0.033 pM AgNPs + 3.4 x 104 pM AmB (0.25 CIM AgNP + 0.125 CIM AmB) combination. Resazurin (blue, nonfluorescent) was reduced by metabolically active cells to resorufin (pink, fluorescent) showing the cytotoxic effect, which was visually weighted. The CompuSyn analysis confirmed synergism between biogenic AgNPs and AmB against C. glabrata. The analysis also shows that the maximal inhibitory activity of the combination is substantially expanded compared to those of the single agents. The IC50 was 0.08 CIM AgNPs and 0.06 CIM AmB (0.01 pM and 1.6x104 pM respectively). Isobolograms demonstrate a stark reduction of the AmB dose when used with AgNP to induce 50% inhibition or greater. Combined therapy has the advantage of attacking different targets by combining several active principles with different mechanisms of action. The development of new approaches has great clinical relevance in the treatment of mycoses.
Fil: Galera, Ivana Laura Delia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; Argentina
Fil: Páez, Paulina Laura. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Paraje, María Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; Argentina
LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology
Argentina
Argentine Society for Biochemistry and Molecular Biology Research
Materia
Antifungal activity
Biogenic nanoparticles
Silver nanoparticles
Candida
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/176910

id CONICETDig_875ccfd164597ff99824896ea7f81849
oai_identifier_str oai:ri.conicet.gov.ar:11336/176910
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrataGalera, Ivana Laura DeliaPáez, Paulina LauraParaje, María GabrielaAntifungal activityBiogenic nanoparticlesSilver nanoparticlesCandidahttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient population. Among the NAC species, Candida glabrata is considered the second or third most frequent causative agent of superficial (oral, esophageal, urinary, and vaginal) or systemic infections, with a high mortality rate. These infections are difficult to treat for their innate resistance to many azole antifungals (ATF) therapy, especially fluconazole. Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents. Silver nanoparticles (AgNPs) are very interesting products currently provided by available nanotechnology to evaluate their antifungal activity. In the present study, the synergism of AgNPs in combination with amphotericin B (AmB) against C. glabrata was investigated. Biogenic AgNPs were synthesized by eco-friendly method, and the antifungal activity against C. glabrata ATCC 2001 was evaluated through determination of Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) according to protocol M27-A3 of Clinical and Laboratory Standards Institute (CLSI). The checkerboard microdilution method was used to study the synergistic combinations of AgNPs with AmB. The results were analyzed using the Fractionary Inhibitory Concentration (FIC) indices, a non-parametric model based on the Loewe additivity theory, and by CompuSyn software. CompuSyn is a computer program for quantitation of synergism and antagonism in drug combinations and the determination of IC50 (drug concentration causing 50% growth inhibition) and ED50 (dose causing 50% of maximum effect) values. Furthermore, we investigated the effects of the resazurin reduction (alamarBlue) assay, which measured metabolically active cells. The same MIC and MFC values were found for AgNP 0.13 pM and for AmB 2.7x105 pM. The FIC index was 0.37 (a FIC index of < 0.5 indicates synergism). This value corresponded to 0.033 pM AgNPs + 3.4 x 104 pM AmB (0.25 CIM AgNP + 0.125 CIM AmB) combination. Resazurin (blue, nonfluorescent) was reduced by metabolically active cells to resorufin (pink, fluorescent) showing the cytotoxic effect, which was visually weighted. The CompuSyn analysis confirmed synergism between biogenic AgNPs and AmB against C. glabrata. The analysis also shows that the maximal inhibitory activity of the combination is substantially expanded compared to those of the single agents. The IC50 was 0.08 CIM AgNPs and 0.06 CIM AmB (0.01 pM and 1.6x104 pM respectively). Isobolograms demonstrate a stark reduction of the AmB dose when used with AgNP to induce 50% inhibition or greater. Combined therapy has the advantage of attacking different targets by combining several active principles with different mechanisms of action. The development of new approaches has great clinical relevance in the treatment of mycoses.Fil: Galera, Ivana Laura Delia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; ArgentinaFil: Páez, Paulina Laura. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaFil: Paraje, María Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; ArgentinaLVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General MicrobiologyArgentinaArgentine Society for Biochemistry and Molecular Biology ResearchTech Science Press2021info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectCongresoJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/176910Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Argentina; 2021; 124-1240327-95451667-5746CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v46nSuppl.1/46213Nacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:42:18Zoai:ri.conicet.gov.ar:11336/176910instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:42:18.889CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
title Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
spellingShingle Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
Galera, Ivana Laura Delia
Antifungal activity
Biogenic nanoparticles
Silver nanoparticles
Candida
title_short Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
title_full Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
title_fullStr Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
title_full_unstemmed Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
title_sort Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata
dc.creator.none.fl_str_mv Galera, Ivana Laura Delia
Páez, Paulina Laura
Paraje, María Gabriela
author Galera, Ivana Laura Delia
author_facet Galera, Ivana Laura Delia
Páez, Paulina Laura
Paraje, María Gabriela
author_role author
author2 Páez, Paulina Laura
Paraje, María Gabriela
author2_role author
author
dc.subject.none.fl_str_mv Antifungal activity
Biogenic nanoparticles
Silver nanoparticles
Candida
topic Antifungal activity
Biogenic nanoparticles
Silver nanoparticles
Candida
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient population. Among the NAC species, Candida glabrata is considered the second or third most frequent causative agent of superficial (oral, esophageal, urinary, and vaginal) or systemic infections, with a high mortality rate. These infections are difficult to treat for their innate resistance to many azole antifungals (ATF) therapy, especially fluconazole. Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents. Silver nanoparticles (AgNPs) are very interesting products currently provided by available nanotechnology to evaluate their antifungal activity. In the present study, the synergism of AgNPs in combination with amphotericin B (AmB) against C. glabrata was investigated. Biogenic AgNPs were synthesized by eco-friendly method, and the antifungal activity against C. glabrata ATCC 2001 was evaluated through determination of Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) according to protocol M27-A3 of Clinical and Laboratory Standards Institute (CLSI). The checkerboard microdilution method was used to study the synergistic combinations of AgNPs with AmB. The results were analyzed using the Fractionary Inhibitory Concentration (FIC) indices, a non-parametric model based on the Loewe additivity theory, and by CompuSyn software. CompuSyn is a computer program for quantitation of synergism and antagonism in drug combinations and the determination of IC50 (drug concentration causing 50% growth inhibition) and ED50 (dose causing 50% of maximum effect) values. Furthermore, we investigated the effects of the resazurin reduction (alamarBlue) assay, which measured metabolically active cells. The same MIC and MFC values were found for AgNP 0.13 pM and for AmB 2.7x105 pM. The FIC index was 0.37 (a FIC index of < 0.5 indicates synergism). This value corresponded to 0.033 pM AgNPs + 3.4 x 104 pM AmB (0.25 CIM AgNP + 0.125 CIM AmB) combination. Resazurin (blue, nonfluorescent) was reduced by metabolically active cells to resorufin (pink, fluorescent) showing the cytotoxic effect, which was visually weighted. The CompuSyn analysis confirmed synergism between biogenic AgNPs and AmB against C. glabrata. The analysis also shows that the maximal inhibitory activity of the combination is substantially expanded compared to those of the single agents. The IC50 was 0.08 CIM AgNPs and 0.06 CIM AmB (0.01 pM and 1.6x104 pM respectively). Isobolograms demonstrate a stark reduction of the AmB dose when used with AgNP to induce 50% inhibition or greater. Combined therapy has the advantage of attacking different targets by combining several active principles with different mechanisms of action. The development of new approaches has great clinical relevance in the treatment of mycoses.
Fil: Galera, Ivana Laura Delia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; Argentina
Fil: Páez, Paulina Laura. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Paraje, María Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto Multidisciplinario de Biología Vegetal. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas Físicas y Naturales. Instituto Multidisciplinario de Biología Vegetal; Argentina
LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology
Argentina
Argentine Society for Biochemistry and Molecular Biology Research
description Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient population. Among the NAC species, Candida glabrata is considered the second or third most frequent causative agent of superficial (oral, esophageal, urinary, and vaginal) or systemic infections, with a high mortality rate. These infections are difficult to treat for their innate resistance to many azole antifungals (ATF) therapy, especially fluconazole. Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents. Silver nanoparticles (AgNPs) are very interesting products currently provided by available nanotechnology to evaluate their antifungal activity. In the present study, the synergism of AgNPs in combination with amphotericin B (AmB) against C. glabrata was investigated. Biogenic AgNPs were synthesized by eco-friendly method, and the antifungal activity against C. glabrata ATCC 2001 was evaluated through determination of Minimum Inhibitory Concentration (MIC50) and Minimum Fungicidal Concentration (MFC) according to protocol M27-A3 of Clinical and Laboratory Standards Institute (CLSI). The checkerboard microdilution method was used to study the synergistic combinations of AgNPs with AmB. The results were analyzed using the Fractionary Inhibitory Concentration (FIC) indices, a non-parametric model based on the Loewe additivity theory, and by CompuSyn software. CompuSyn is a computer program for quantitation of synergism and antagonism in drug combinations and the determination of IC50 (drug concentration causing 50% growth inhibition) and ED50 (dose causing 50% of maximum effect) values. Furthermore, we investigated the effects of the resazurin reduction (alamarBlue) assay, which measured metabolically active cells. The same MIC and MFC values were found for AgNP 0.13 pM and for AmB 2.7x105 pM. The FIC index was 0.37 (a FIC index of < 0.5 indicates synergism). This value corresponded to 0.033 pM AgNPs + 3.4 x 104 pM AmB (0.25 CIM AgNP + 0.125 CIM AmB) combination. Resazurin (blue, nonfluorescent) was reduced by metabolically active cells to resorufin (pink, fluorescent) showing the cytotoxic effect, which was visually weighted. The CompuSyn analysis confirmed synergism between biogenic AgNPs and AmB against C. glabrata. The analysis also shows that the maximal inhibitory activity of the combination is substantially expanded compared to those of the single agents. The IC50 was 0.08 CIM AgNPs and 0.06 CIM AmB (0.01 pM and 1.6x104 pM respectively). Isobolograms demonstrate a stark reduction of the AmB dose when used with AgNP to induce 50% inhibition or greater. Combined therapy has the advantage of attacking different targets by combining several active principles with different mechanisms of action. The development of new approaches has great clinical relevance in the treatment of mycoses.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Congreso
Journal
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/176910
Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Argentina; 2021; 124-124
0327-9545
1667-5746
CONICET Digital
CONICET
url http://hdl.handle.net/11336/176910
identifier_str_mv Antifungal activity of biogenic silver nanoparticles in combination with amphotericin B on Candida glabrata; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Argentina; 2021; 124-124
0327-9545
1667-5746
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v46nSuppl.1/46213
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.coverage.none.fl_str_mv Nacional
dc.publisher.none.fl_str_mv Tech Science Press
publisher.none.fl_str_mv Tech Science Press
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613333076934656
score 13.069144